613 related articles for article (PubMed ID: 27117585)
1. Bacterial superglue enables easy development of efficient virus-like particle based vaccines.
Thrane S; Janitzek CM; Matondo S; Resende M; Gustavsson T; de Jongh WA; Clemmensen S; Roeffen W; van de Vegte-Bolmer M; van Gemert GJ; Sauerwein R; Schiller JT; Nielsen MA; Theander TG; Salanti A; Sander AF
J Nanobiotechnology; 2016 Apr; 14():30. PubMed ID: 27117585
[TBL] [Abstract][Full Text] [Related]
2. Bacterial superglue generates a full-length circumsporozoite protein virus-like particle vaccine capable of inducing high and durable antibody responses.
Janitzek CM; Matondo S; Thrane S; Nielsen MA; Kavishe R; Mwakalinga SB; Theander TG; Salanti A; Sander AF
Malar J; 2016 Nov; 15(1):545. PubMed ID: 27825348
[TBL] [Abstract][Full Text] [Related]
3. Improving the malaria transmission-blocking activity of a Plasmodium falciparum 48/45 based vaccine antigen by SpyTag/SpyCatcher mediated virus-like display.
Singh SK; Thrane S; Janitzek CM; Nielsen MA; Theander TG; Theisen M; Salanti A; Sander AF
Vaccine; 2017 Jun; 35(30):3726-3732. PubMed ID: 28578824
[TBL] [Abstract][Full Text] [Related]
4. SpyTag/SpyCatcher display of influenza M2e peptide on norovirus-like particle provides stronger immunization than direct genetic fusion.
Lampinen V; Gröhn S; Soppela S; Blazevic V; Hytönen VP; Hankaniemi MM
Front Cell Infect Microbiol; 2023; 13():1216364. PubMed ID: 37424789
[TBL] [Abstract][Full Text] [Related]
5. Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization.
Brune KD; Leneghan DB; Brian IJ; Ishizuka AS; Bachmann MF; Draper SJ; Biswas S; Howarth M
Sci Rep; 2016 Jan; 6():19234. PubMed ID: 26781591
[TBL] [Abstract][Full Text] [Related]
6. Development of a Tag/Catcher-mediated capsid virus-like particle vaccine presenting the conserved
Martinez FG; Zielke RA; Fougeroux CE; Li L; Sander AF; Sikora AE
Infect Immun; 2023 Dec; 91(12):e0024523. PubMed ID: 37916806
[TBL] [Abstract][Full Text] [Related]
7. A Universal Plug-and-Display Vaccine Carrier Based on HBsAg VLP to Maximize Effective Antibody Response.
Marini A; Zhou Y; Li Y; Taylor IJ; Leneghan DB; Jin J; Zaric M; Mekhaiel D; Long CA; Miura K; Biswas S
Front Immunol; 2019; 10():2931. PubMed ID: 31921185
[TBL] [Abstract][Full Text] [Related]
8. Display of Streptococcus iniae α-Enolase on the Surface of Virus-Like Particles (VLPs) of Nervous Necrosis Virus (NNV) Using SpyTag/SpyCatcher.
Yang JI; Kim KH
Mar Biotechnol (NY); 2022 Dec; 24(6):1066-1072. PubMed ID: 36171522
[TBL] [Abstract][Full Text] [Related]
9. Virus-like particle-display of the enterotoxigenic Escherichia coli heat-stable toxoid STh-A14T elicits neutralizing antibodies in mice.
Govasli ML; Diaz Y; Puntervoll P
Vaccine; 2019 Oct; 37(43):6405-6414. PubMed ID: 31515145
[TBL] [Abstract][Full Text] [Related]
10. A nanoparticle vaccine displaying the ookinete PSOP25 antigen elicits transmission-blocking antibody response against Plasmodium berghei.
Yao G; Min H; Yu X; Liu F; Cui L; Cao Y
Parasit Vectors; 2023 Nov; 16(1):403. PubMed ID: 37932796
[TBL] [Abstract][Full Text] [Related]
11. A Novel Virus-Like Particle Based Vaccine Platform Displaying the Placental Malaria Antigen VAR2CSA.
Thrane S; Janitzek CM; Agerbæk MØ; Ditlev SB; Resende M; Nielsen MA; Theander TG; Salanti A; Sander AF
PLoS One; 2015; 10(11):e0143071. PubMed ID: 26599509
[TBL] [Abstract][Full Text] [Related]
12. Engineering a Virus-Like Particle as an Antigenic Platform for a Pfs47-Targeted Malaria Transmission-Blocking Vaccine.
Yenkoidiok-Douti L; Williams AE; Canepa GE; Molina-Cruz A; Barillas-Mury C
Sci Rep; 2019 Nov; 9(1):16833. PubMed ID: 31727945
[TBL] [Abstract][Full Text] [Related]
13. A VAR2CSA:CSP conjugate capable of inducing dual specificity antibody responses.
Sungwa M; Susan T; Mikkel JC; Adolph KR; Boniface MS; Grundtvig TT; Ali S; Agertoug NM; Frederik SA
Afr Health Sci; 2017 Jun; 17(2):373-381. PubMed ID: 29062332
[TBL] [Abstract][Full Text] [Related]
14. Modular vaccine platform based on the norovirus-like particle.
Lampinen V; Heinimäki S; Laitinen OH; Pesu M; Hankaniemi MM; Blazevic V; Hytönen VP
J Nanobiotechnology; 2021 Jan; 19(1):25. PubMed ID: 33468139
[TBL] [Abstract][Full Text] [Related]
15. Nanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccines.
Leneghan DB; Miura K; Taylor IJ; Li Y; Jin J; Brune KD; Bachmann MF; Howarth M; Long CA; Biswas S
Sci Rep; 2017 Jun; 7(1):3811. PubMed ID: 28630474
[TBL] [Abstract][Full Text] [Related]
16. Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties.
Liu Y; Zhou J; Yu Z; Fang D; Fu C; Zhu X; He Z; Yan H; Jiang L
BMC Microbiol; 2014 Dec; 14():233. PubMed ID: 25520151
[TBL] [Abstract][Full Text] [Related]
17. Chimeric Virus-like Particles of Universal Antigen Epitopes of Coronavirus and Phage Qβ Coat Protein Trigger the Production of Neutralizing Antibodies.
Guo Y; Guo R; Ma Y; Chang W; Ming S; Yang G; Guo Y
Curr Top Med Chem; 2021 Oct; 21(14):1235-1250. PubMed ID: 34145995
[TBL] [Abstract][Full Text] [Related]
18. Bovine papillomavirus prostate cancer antigen virus-like particle vaccines are efficacious in advanced cancers in the TRAMP mouse spontaneous prostate cancer model.
Simons BW; Cannella F; Rowley DT; Viscidi RP
Cancer Immunol Immunother; 2020 Apr; 69(4):641-651. PubMed ID: 32016503
[TBL] [Abstract][Full Text] [Related]
19. Lung CD8+ T Cell Impairment Occurs during Human Metapneumovirus Infection despite Virus-Like Particle Induction of Functional CD8+ T Cells.
Wen SC; Schuster JE; Gilchuk P; Boyd KL; Joyce S; Williams JV
J Virol; 2015 Sep; 89(17):8713-26. PubMed ID: 26063431
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
